Clinical Trial: ALLIANCE A091903

ALLIANCE A091903

Status: Open

A Randomized Phase II Trial of Adjuvant Nivolumab with or Without Cabozantinib in Patients with Resected Mucosal Melanoma

A091903 is temporarily closed to new patient accrual to Pre-registration of Advanced Arm 3, effective June 16, 2025.